Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timon Heide

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Oncotarget|September 28, 2016
Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroupPhilipp H Baldia, Angela Maurer, Timon Heide, et al.
Epigenetics|September 15, 2016
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patientsMartin Schlensog, Lara Magnus, Timon Heide, et al.
Nature Communications|March 30, 2020
Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal trackingGeorge D Cresswell, Daniel Nichol, Inmaculada Spiteri, et al.
The Journal of Pathology|February 6, 2019
Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapyTimon Heide, Angela Maurer, Monika Eipel, et al.
Nucleic Acids Research|September 18, 2025
Enspyre: a novel enrichment technology for selected DNA variants using pyrophosphorolysisKatarzyna A Anton, Timon Heide, Paulina K Powalowska-Pickton, et al.
Nature Genetics|September 4, 2020
Subclonal reconstruction of tumors by using machine learning and population geneticsGiulio Caravagna, Timon Heide, Marc J Williams, et al.
Molecular Cancer|February 25, 2017
ITIH5 mediates epigenetic reprogramming of breast cancer cellsMichael Rose, Vera Kloten, Erik Noetzel, et al.
Cancer Research|June 11, 2025
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype ParadigmErica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos, et al.
Nature Communications|December 10, 2017
Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolutionAnn-Marie Baker, Weini Huang, Xiao-Ming Mindy Wang, et al.
Nature Genetics|November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolutionEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Oncotarget|September 28, 2016
Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroupPhilipp H Baldia, Angela Maurer, Timon Heide, et al.
Epigenetics|September 15, 2016
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patientsMartin Schlensog, Lara Magnus, Timon Heide, et al.
Nature Communications|March 30, 2020
Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal trackingGeorge D Cresswell, Daniel Nichol, Inmaculada Spiteri, et al.
The Journal of Pathology|February 6, 2019
Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapyTimon Heide, Angela Maurer, Monika Eipel, et al.
Nucleic Acids Research|September 18, 2025
Enspyre: a novel enrichment technology for selected DNA variants using pyrophosphorolysisKatarzyna A Anton, Timon Heide, Paulina K Powalowska-Pickton, et al.
Nature Genetics|September 4, 2020
Subclonal reconstruction of tumors by using machine learning and population geneticsGiulio Caravagna, Timon Heide, Marc J Williams, et al.
Molecular Cancer|February 25, 2017
ITIH5 mediates epigenetic reprogramming of breast cancer cellsMichael Rose, Vera Kloten, Erik Noetzel, et al.
Cancer Research|June 11, 2025
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype ParadigmErica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos, et al.
Nature Communications|December 10, 2017
Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolutionAnn-Marie Baker, Weini Huang, Xiao-Ming Mindy Wang, et al.
Nature Genetics|November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolutionEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Pageof 3